For type 2 diabetes , GLP-1 receptor agonists are generally considered a long-term treatment, as diabetes is a chronic progressive condition requiring ongoing management
The Lancet Diabetes & Endocrinology , 5(1), 4151
Comparison of GLP-1 Drugs Ozempic, Wegovy and Rybelsus all use semaglutide as their main ingredient, but they have different doses and approved uses
GLP-1 drugs help control blood sugar and reduce appetite
Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy
During this phase, your provider establishes your therapeutic doses based on lab response and symptom improvement